(R)-3,3'-DIMETHYL-1,1'-BINAPHTHALENE-2,2'-DIOL
|
|
(R)-3,3'-DIMETHYL-1,1'-BINAPHTHALENE-2,2'-DIOL 속성
- 녹는점
- 203-204 °C(Solv: dichloromethane (75-09-2); hexane (110-54-3))
- 끓는 점
- 461.2±40.0 °C(Predicted)
- 밀도
- 1.245±0.06 g/cm3(Predicted)
- 산도 계수 (pKa)
- 8.61±0.50(Predicted)
안전
- 위험 및 안전 성명
- 위험 및 사전주의 사항 (GHS)
그림문자(GHS): | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
신호 어: | Warning | ||||||||||||||||||||||||||||
유해·위험 문구: |
|
||||||||||||||||||||||||||||
예방조치문구: |
|
(R)-3,3'-DIMETHYL-1,1'-BINAPHTHALENE-2,2'-DIOL C화학적 특성, 용도, 생산
(R)-3,3'-DIMETHYL-1,1'-BINAPHTHALENE-2,2'-DIOL 준비 용품 및 원자재
원자재
준비 용품
(R)-3,3'-DIMETHYL-1,1'-BINAPHTHALENE-2,2'-DIOL 공급 업체
글로벌( 29)공급 업체
공급자 | 전화 | 이메일 | 국가 | 제품 수 | 이점 |
---|---|---|---|---|---|
CR Corporation Lomited | |
fred.wen@crcorporation.cn | CHINA | 12069 | 58 |
Hangzhou MolCore BioPharmatech Co.,Ltd. | +86-057181025280; +8617767106207 |
sales@molcore.com | China | 49739 | 58 |
Shanghai Acmec Biochemical Technology Co., Ltd. | +undefined18621343501 |
product@acmec-e.com | China | 33350 | 58 |
Aladdin Scientific | +1-+1(833)-552-7181 |
sales@aladdinsci.com | United States | 57511 | 58 |
Shanghai Likang New Materials Co., Limited | +86-16631818819 +86-17736933208 |
3684455296@qq.com | China | 9311 | 58 |
Amadis Chemical Company Limited | 571-89925085 |
sales@amadischem.com | China | 131980 | 58 |
Daicel Chiral Technologies (China)CO.,LTD | 021-50460086-9 15921403865 |
han_yajun@dctc.daicel.com | China | 7176 | 65 |
Tianjin Derchemist Science & Technology Co., Ltd. | 22-58627059 13920586291 |
zdcomcon@126.com | China | 3166 | 50 |
Bide Pharmatech Ltd. | 400-1647117 15221909166 |
product02@bidepharm.com | China | 41438 | 60 |
Shanghai Chiral bio-compound co., Ltd. | 021-5068 3667/17749785980/1029026415; 17749785980 |
1029026415@qq.com | China | 2884 | 58 |
(R)-3,3'-DIMETHYL-1,1'-BINAPHTHALENE-2,2'-DIOL 관련 검색:
S-3,3'-di-9-phenanthrenyl-5,5',6,6',7,7',8,8'-octahydro-1,1'-Binaphthalene]-2,2'-diol
R-3,3'-bis(3,5-bis(trifluoroMethyl)phenyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-bi-2,2'-naphthol
R-3,3'-bis([1,1'-biphenyl]-4-yl)-5,5',6,6',7,7',8,8'-octahydro-[1,1'-Binaphthalene]-2,2'-diol
S-5,5',6,6',7,7',8,8'-octahydro-3,3'-diphenyl-[1,1'-Binaphthalene]-2,2'-diol
S-3,3'-bis((2-Naphthyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-bi-2,2'-naphthol
3,3'-diiodo-2,2'-dimethoxy-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthalene
(3R)-3,3'-bis(perfluorophenyl)-[1,1'-binaphthalene]-2,2'-diol
(R)-5,5',6,6',7,7',8,8'-Octahydro-3,3'-bis(4-nitrophenyl)-[1,1'-binaphthalene]-2,2'-diol
(R)-3,3'-DIMETHYL-1,1'-BINAPHTHALENE-2,2'-DIOL
S-3,3'-bis[4-(trifluoroMethyl)phenyl]-5,5',6,6',7,7',8,8'-octahydro-[1,1'-Binaphthalene]-2,2'-diol
R-3,3'-bis[4-(trifluoroMethyl)phenyl]-5,5',6,6',7,7',8,8'-octahydro-[1,1'-Binaphthalene]-2,2'-diol
R-3,3'-bis(2-Naphthyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-bi-2,2'-naphthol
S-3-3'-Bis(3,5-bis(methyl)phenyl)-1,1'-bi-2-naphthol
(R)-5,5',6,6',7,7',8,8'-Octahydro-3,3'-bis(4-methoxyphenyl)-[1,1'-binaphthalene]-2,2'-diol
R-3,3'-bis(3,5-diMethylphenyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-bi-2,2'-naphthol
R-5,5',6,6',7,7',8,8'-octahydro-3,3'-diphenyl-[1,1'-Binaphthalene]-2,2'-diol
R-3-3'-Bis(3,5-bis(methyl)phenyl)-1,1'-bi-2-naphthol